Certain companies may be covered by FRC under an issuer paid model. FRC or companies with related management, and Analysts, may hold shares/securities in some companies mentioned in this section. This creates a potential conflict of interest which readers should consider.

Investor webinar: Delta 9 Cannabis Inc.
Topic: Aphria/Tilray Merger and Potential for Consolidation in 2021 Sid Rajeev, FRC's Head of Research, will discuss the impact of Aphria and Tilray's merger, the potential for further consolidation in the space in 2021, and tips for picking M&A targets. John Arbuthnot Delta 9's Co-Founder and CEO will talk about their latest product for decontamination, COVID-19 vaccine storage, and plans to ramp up their retail footprint in 2021.